CSL-Ltd-CSLAX-Deep-dive-into-Pipeline-A12-to-Target-Price.pdf
This is a recently released Goldman Sachs report detailing the current R&D landscape for CSL. It provides the rational behind their $312 target price. Of course, with all broker reports you have to take them with a grain of salt. However, they explore each of the 15 projects in/near active development, assessing the data and the likely regulatory pathway and financial impact. Awesome read for anyone wanted a breakdown of the underlying molecules, the target markets and the overall opportunities. I feel sorry for the intern Riashad Monjur, who gets a brief shoutout for probably writing the whole thing. As usual DYOR.
Goldman Sachs R&D Report
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$283.05 |
Change
3.470(1.24%) |
Mkt cap ! $136.7B | |||
| Open | High | Low | Value | Volume |
| $281.90 | $284.50 | $281.02 | $168.3M | 594.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1012 | $283.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $283.47 | 3676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$283.87 |
Change
3.470 ( 1.68 %) |
||||
| Open | High | Low | Volume | ||
| $282.06 | $284.50 | $281.58 | 26577 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| CSL (ASX) Chart |